FREQUENTLY ASKED QUESTIONS

Peptide therapy uses precisely dosed, physician-prescribed compounds to support specific outcomes — like metabolism, recovery, or performance — rather than a one-size-fits-all approach. Every Motion protocol is built around your goals, your labs, and your biology, and is reviewed by a licensed clinician before it ships.

Yes. Motion connects you with independent, licensed clinicians who evaluate your intake (and labs, when needed) before anything is prescribed. Nothing ships without a clinician's review and approval — this isn't a research-chemical storefront.

You start with a short online intake covering your goals, health history, and current medications. Depending on what you're pursuing, your clinician may request labs. From there, they build a protocol calibrated to you, walk you through it, and your first shipment ships discreetly and cold-packed.

When prescribed and monitored by a licensed clinician, and compounded by an FDA-registered 503A pharmacy, peptide therapy has a well-established safety profile for its approved and off-label uses. Like any medication, it carries risks and isn't right for everyone — your clinician will screen for contraindications before prescribing and check in with you as you progress.

Your intake, labs, and clinical records are handled the same way any telehealth provider handles protected health information, and shipments arrive in discreet, unmarked packaging. You can review our full privacy practices in the Privacy & Terms section of the site.

GLP-1 receptor agonists mimic a natural gut hormone that regulates appetite, slows gastric emptying, and improves insulin response. In practice, most people notice reduced appetite and fewer food cravings, which supports gradual, sustained weight loss alongside other lifestyle changes.

Semaglutide targets the GLP-1 receptor alone, while tirzepatide targets both the GLP-1 and GIP receptors, which for many patients translates to a stronger metabolic and appetite-suppressing effect. Your clinician will factor in your goals, prior response, and tolerability when recommending one over the other.

The most common side effects are gastrointestinal — nausea, constipation, or reflux — and tend to be strongest during dose increases before settling down. Motion protocols start low and titrate gradually specifically to minimize these effects, and your clinician adjusts your dose based on how you're tolerating it.

Most patients notice reduced appetite within the first couple of weeks, with visible weight change typically building over 8-12 weeks as the dose titrates upward. Results vary by starting point, dose, and adherence to the protocol — your clinician will set expectations specific to you.

Not necessarily — some patients use GLP-1s for a defined period to reach a goal and then taper with clinician guidance, while others continue longer-term to maintain results, since appetite and weight often trend back up after stopping. This is a conversation to have directly with your clinician as you approach your goal.

These are peptides studied for their potential to support soft-tissue repair, reduce inflammation, and speed recovery from training or injury. They're generally used as part of a broader recovery plan rather than a standalone fix — your clinician will explain how they fit alongside rest, rehab, and training modifications.

Most recovery peptides are administered as a small subcutaneous injection, similar to how insulin is dosed, and Motion provides clear instructions and support so you're comfortable doing it yourself. Some formulations are also available in other delivery forms depending on the protocol.

Most recovery protocols run several weeks to a few months, depending on what you're recovering from and how you respond. Your clinician will set a specific timeline and reassess with you at check-in points along the way.

Most recovery peptides used in compounded protocols are not individually FDA-approved for these uses; they're prescribed off-label based on clinical judgment and compounded by FDA-registered 503A pharmacies. Your clinician will walk you through the evidence and what to realistically expect before you start.

Often, yes — recovery peptides are frequently used alongside physical therapy, structured training plans, or other peptide protocols like GLP-1s or growth hormone secretagogues. Your clinician reviews everything you're currently taking to check for interactions before adding anything new.

Growth hormone secretagogues, like Ipamorelin and CJC-1295, are peptides that signal your pituitary gland to release more of your own growth hormone, rather than introducing synthetic HGH directly. That's the core distinction most patients want to understand before starting.

Synthetic HGH replaces growth hormone directly, while secretagogues stimulate your body to produce more of its own, generally in a more pulsatile, physiologic pattern. Many patients and clinicians prefer this approach for its more moderate, gradual effect profile.

Common goals include improved recovery and sleep quality, gradual changes in body composition, and general vitality — these effects tend to build over months rather than weeks. Your clinician will help set realistic, individualized expectations based on your age, baseline levels, and goals.

Motion's protocols are designed for adults, and your clinician will factor in your age, hormone levels, and health history when determining candidacy. This isn't appropriate for anyone still going through natural growth and development.

Your clinician will typically use baseline labs (like IGF-1) to establish a starting point, then periodic follow-up labs and check-ins to track your response and adjust the protocol. This ongoing monitoring is part of what keeps dosing appropriate for you specifically.